Prostate cancer prevention trial yields positive results, but with a few cautions.
Open Access
- 15 July 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 95 (14) , 1030-1031
- https://doi.org/10.1093/jnci/95.14.1030
Abstract
The Prostate Cancer Prevention Trial, a randomized placebo-controlled study involving nearly 19,000 men at 221 sites over 10 years, has shown that men who took the drug finasteride reduced their risk of getting prostate cancer by about 25%.Keywords
This publication has 0 references indexed in Scilit: